ITRM
Gabelli & Co gives a Hold recommendation for Iterum Therapeutics Plc (ITRM)
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
The Potential Rise in the Price of Iterum Therapeutics Plc (ITRM) following insiders activity
Iterum Therapeutics Plc’s recent filing unveils that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov ...
Gabelli & Co gives a Hold recommendation for Iterum Therapeutics Plc (ITRM)
Iterum Therapeutics Plc’s recently made public that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov ...
ITRM stock rated a Hold by Gabelli & Co
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
A Guide To The Risks Of Investing In Iterum Therapeutics Plc (ITRM)
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
Understanding the Risks of Investing in Iterum Therapeutics Plc (ITRM)
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $2191.0 on Nov 18 ...
